Recall of BD GasPak EZ Campy Pouch System for Low CO2 Levels
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Becton Dickinson & Co. is recalling 2,200 units of the BD GasPak EZ Campy Pouch System due to potential issues with carbon dioxide production below specifications.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on May 14, 2026 and geographically references United States. Its severity classification of "low" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
Becton Dickinson & Co. is recalling certain lots of the BD GasPak EZ Campy Pouch System because the gas generating sachets may produce carbon dioxide levels below specification, affecting its intended use for microbiologic purposes.
Which Products Are Affected
The affected product is the BD GasPak EZ Campy Pouch System with Catalog Number: 260685, UDI-DI: 30382902606858, and Lot Number: 5329863. A total of 2,200 units are involved in this recall. The distribution includes US Nationwide and the country of Hong Kong as part of worldwide distribution.
What You Should Do
Consumers should follow the initial firm notification, which was issued via letter, and contact Becton Dickinson & Co. regarding the recall for further instructions on returns or refunds.
Why This Matters
This recall is significant because it could impact the reliability of microbiologic testing, potentially affecting diagnostic accuracy in a professional setting.
Source
Attribution: FDA Recall Number Z-1983-2026. For more information, refer to the FDA's official recall database.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,091 characters here).
Similar severity timing
Same severity (low) notices issued closest in time to May 14, 2026.
Frequently Asked Questions
Common questions about this FDA recall.